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CASE REPORTS
Ipsilateral femoral vein compression: A
contraindication to thrombin injection of femoral
pseudoaneurysms
Benjamin Hung, MD,a Bertrand Gallet, MD,b and Timothy C. Hodges, MD,a Kansas City, Mo
Development of a femoral artery pseudoaneurysm occurs in 0.6% to 3.2% of interventional procedures. Nonsurgical
treatment has consisted of ultrasound scan–directed compression and, more recently, direct thrombin injection into the
pseudoaneurysm cavity to achieve thrombosis. Reported complications after thrombin injection are rare. We report two
cases of femoral venous compression associated with pseudoaneurysm injection and review the literature. A 76-year-old
man and an 86-year-old man both underwent thrombin injection of pseudoaneurysms compressing the ipsilateral
common femoral vein. Both patients were diagnosed with deep venous thrombosis and subsequently needed surgical
exploration for repair of the pseudoaneurysm and release of the venous compression. At exploration, both were found to
have significant inflammation surrounding the femoral vessels, which made vessel exposure challenging. Because of the
venous outflow obstruction involved in femoral pseudoaneurysms with secondary venous compression and the surgical
difficulty caused by surrounding inflammation, avoidance of thrombin injection in favor of early surgical intervention is
suggested. (J Vasc Surg 2002;35:1280-3.)
Pseudoaneurysm formation is a recognized complica-
tion after femoral artery cannulation for angiographic pro-
cedures. The incidence of this complication is increased
when coronary stent placement is performed.1,2 Histori-
cally, surgical exploration with arterial repair has been the
treatment of choice. In the past decade, however, other
techniques, including ultrasound scan–guided compres-
sion3 and direct thrombin injection,4 have met with success
in the treatment of this complication. Few significant side
effects have been reported with thrombin injection. These
complications include arterial thrombosis and emboliza-
tion,5,6 infection,7 urticaria,8 and anaphylaxis.9 Our case
reports describe our experience with two patients who were
diagnosed with deep venous thrombosis (DVT) as the
result of compression of the femoral vein by a femoral
pseudoaneurysm treated with thrombin injection.
CASE REPORT
Case 1. A 76-year-old male with a history of coronary artery
disease and interventions, including a prior angioplasty of the left
anterior descending artery, was undergoing evaluation for unstable
angina. The symptom of recurrent chest discomfort, which was
originally controlled medically, began to progress. Coronary an-
giography was performed with standard Seldinger technique via
the right common femoral artery. After cannulation, an 8F sheath
was placed over a guidewire. The study results revealed a high-
grade lesion in the proximal circumflex artery. The patient under-
went percutaneous transluminal coronary angioplasty of the prox-
imal first obtuse marginal branch of the left circumflex artery, and
a 2.5 18–mm TriStar stent (Guidant Corporation, Indianapolis,
Ind) was deployed without apparent complication. Antiplatelet
therapy with abciximab (ReoPro, Eli Lilly, Indianapolis, Ind) was
initiated and continued for 12 hours after the procedure. The
sheath then was removed without significant problems. No closure
device was used after sheath removal. A small groin hematoma was
noted on physical examination, but no bruit was detected. The
patient was discharged to home on clopidogrel bisulfate (Plavix,
Sanofi, New York, NY) therapy without further incident on the
following day. Routine 1-week follow-up examination results re-
vealed a bruit in the previously instrumented groin on physical
examination and significant edema of the right leg. Lower extrem-
ity duplex scan examination results revealed a narrow-necked,
partially thrombosed 3.5 4.4 2.0–cm pseudoaneurysm arising
from the anterior aspect of the right common femoral artery.
Turbulent arterial flow was shown in the pseudoaneurysm sac, and
this finding was thought to explain the bruit. There was no
evidence of an arteriovenous fistula, and the right common femoral
vein was noted to be occluded.
On the basis of these findings, pseudoaneurysm closure with
thrombin injection was undertaken. A total of 162 pseudoaneu-
rysm injections have been performed in our radiology department.
Percutaneous ultrasound scan–guided injection of 400 units of
thrombin was performed. Subsequent duplex scan examination
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results revealed complete thrombosis of the pseudoaneurysm.
Waveforms in the femoral artery remained triphasic, and distal
pulses were unchanged on examination results. The patient was
admitted to the hospital, femoral DVT was treated with intrave-
nous heparin for 4 days, and warfarin sodium therapy was initiated.
The lower extremity edema improved clinically, and the patient
was discharged to home with an international normalized ratio in
the 2.3 to 2.5 range.
However, the following week, worsening edema and pain in
the right leg that limited the ability to ambulate developed. Duplex
scan examination results revealed progression of the femoral ve-
nous thrombus into the popliteal and tibial veins, on the basis of
incompressibility of the venous system, and thrombosis of the
previously noted pseudoaneurysm. The patient was readmitted for
progression of DVT despite adequate anticoagulation therapy.
Evaluation for a possible hypercoagulable state was initiated, and a
vascular surgical consultation was obtained. At the recommenda-
tion of the surgeon, a computed tomographic (CT) scan of the
abdomen and pelvis was performed. The scan results revealed no
evidence of pelvic masses or other causes of pelvic venous compres-
sion. The results did, however, reveal a 3.1  2.7–cm pseudoan-
eurysm of the right common femoral artery (Fig 1). There was
calcification noted within the posteromedial pseudoaneurysm wall.
The cause of the calcification was unknown; the patient did not
have a previously known femoral aneurysm nor was one noted at
the cardiac catheterization procedure. Mild edema and inflamma-
tory changes were also shown in this region. Most significantly, the
common femoral vein appeared markedly compressed by this
process, and thrombus was present in the vein distally.
With these findings, the patient was taken to the operating
room where a right femoral exploration was performed. Immedi-
ately after skin incision, we noted a severe inflammatory reaction in
the soft tissues surrounding the femoral artery and vein. This
reactive mass, which included the pseudoaneurysm, contained
marked calcification and appeared to be compressing the lumen of
the common femoral vein completely. After dissection, the inflam-
matory mass was mobilized and excised, thus releasing the venous
compression. The common femoral artery had no evidence of
chronic aneurysmal disease and needed no additional repair. The
femoral vein immediately reexpanded, and venous flow was con-
firmed with intraoperative continuous-wave Doppler scan results.
Despite the previous findings on duplex scan examination and CT
scan, no thrombus was visible in the vein before or after decom-
pression. No other abnormality was found and the wound was
closed.
The patient’s postoperative course was unremarkable. He had
no clinical evidence of a pulmonary embolus. The lower extremity
edema and pain improved, and the patient was discharged home on
warfarin sodium therapy. At the routine office follow-up examina-
tion 2 weeks later, the patient was without clinical evidence of
recurrent DVT or edema.
Case 2. An 86-year-old male with a history of rheumatic heart
disease status after placement of a Bjork-Shiley (Shiley, Inc, Irvine,
Calif) aortic valve replacement underwent evaluation for lifestyle-
limiting right lower extremity claudication. The patient was under-
going warfarin sodium therapy to maintain an elevated interna-
tional normalized ratio. An aortogram with lower extremity runoff
views was performed via a left common femoral artery percutane-
ous access. The study results revealed a stenosis of the midportion
and distal superficial femoral artery on the right. Initially, a 6F
sheath was placed in the left common femoral artery and was
exchanged for an 8F sheath when a transluminal angioplasty of the
right superficial femoral artery was performed with a 6  2–cm
Power Flex balloon (Cordis Corporation, Piscataway, NJ). The
sheath was removed without apparent difficulty. No arterial closure
device was used.
Five days later, the patient noted increasing swelling of the left
lower extremity. A lower extremity venous duplex scan was ob-
tained, and results revealed a 5-cm common femoral artery pseu-
doaneurysm compressing the left common femoral vein, raising
suspicion for a secondary DVT. The patient was admitted to the
hospital. With local anesthesia, 400 units of reconstituted bovine
thrombin were injected into the pseudoaneurysm. Although the
main portion of the pseudoaneurysm was noted to be thrombosed
after the injection, the neck of the aneurysm did not undergo
thrombosis. Subsequent duplex scan results later that same day
revealed a patent 3-cm pseudoaneurysm cavity. Vascular surgical
consultation was obtained.
A pelvic CT scan was obtained (Fig 2). The study results
showed the pseudoaneurysm and obstructive compression of the
Fig 1. Computed tomographic scan of common femoral artery
pseudoaneurysm, common femoral vein compression, and sur-
rounding inflammatory change.
Fig 2. Computed tomography scan of common femoral artery
pseudoaneurysm with common femoral vein compression.
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common femoral vein. The femoral vein distal to the point of
obstruction was noted to be dilated. The patient was taken to the
operating room, at which time the pseudoaneurysm cavity was
opened and the common femoral artery was repaired with direct
oversew of the arteriotomy. The pseudoaneurysm wall was noted
to be markedly inflamed, making dissection quite difficult. The
common femoral vein was freed from this inflammatory mass. As
with our previous case, with external inspection, no thrombus was
visible in the common femoral vein. The patient’s postoperative
course was unremarkable. Subsequent duplex scan results 3 days
later revealed normal flow in the left femoral venous system and no
evidence of obstruction or thrombus.
DISCUSSION
With increasing cardiac and peripheral vascular inter-
ventional techniques during the past three decades, femoral
artery cannulation has become a common procedure. With
this increase in access cases, a growing number of iatrogenic
pseudoaneurysms occur. Historically, 0.6% to 1.0% of di-
agnostic catheterizations have resulted in this complica-
tion.10 Even higher rates of pseudoaneurysm formation
have been reported with therapeutic interventions (2.0% to
3.2%).1,2 This increase in frequency appears to result from
larger arteriotomies produced by larger diameter sheaths
needed for balloon angioplasty or deployment of vascular
stents.
The traditional treatment of femoral pseudoaneurysms
has been surgical exploration with repair of the arterial
defect. However, in the early 1990s, a new technique began
to replace surgery as the preferred method for treatment of
these pseudoaneurysms. Ultrasound scan–guided com-
pression was first described by Fellmeth et al11 in 1991. The
principle behind this technique is that direct visualization
with B-mode ultrasound scan allows localized compression
of the pseudoaneurysm neck, leading to thrombosis. The
success rate of this approach was satisfactory (55% to 95%;
mean, 75%) in several studies.2,3,12 This technique gained
widespread acceptance because of its relative safety and
avoidance of surgery in these often fragile conditions. As a
result of the ease and success of this technique, surgical
repair is now reserved for those patients with complicated
pseudoaneurysms or those cases that fail ultrasound scan–
guided compression. However, this practice was not with-
out disadvantages. Failure rates were found to be higher if
the patient underwent anticoagulation therapy13 or if the
pseudoaneurysm was larger than 4 cm in diameter.2,3 In
addition, patient tolerance also affects the success rate.
Because this technique requires a mean of 37 minutes
(range, 10 to 110 minutes)14 of localized compression and
intravenous sedation, a certain number of patients cannot
tolerate the pressure needed to achieve closure.
In 1998, Kang et al4 tested ultrasound scan–guided
thrombin injection into the pseudoaneurysm sac. During a
17-month period, 20 consecutive patients with 21
pseudoaneurysms underwent thrombin injection with 0.5
to 1.0 mL of a solution of bovine thrombin (1000 units/
mL). Repeat injection was performed if flow were still
shown with duplex examination results. Fifteen pseudoan-
eurysms (71%) thrombosed within 20 seconds and five
more responded to a second injection, for a total success
rate of 95%. The benefits of this procedure were that
anticoagulation therapy status did not seem to have an
effect on the success rate. Also, this procedure was well
tolerated, with no patients describing major discomfort. In
the study from Tamim et al,15 three of 10 patients (30%)
reported mild discomfort in the groin with none reporting
actual pain. No complications were reported, measured
ankle-brachial indices were unchanged after the procedure,
and vascular integrity was maintained. Further work, in-
cluding that of Paulson et al,7 has duplicated the success
rate (25 of 26 patients; 96%) of the initial study, again with
no report of complications. Kang et al16 have subsequently
published reports confirming the original study success
rates.
Recent reports have documented possible complica-
tions associated with thrombin injection therapy. One of
the first case reports describes acute upper extremity isch-
emia after injection of a brachial artery pseudoaneurysm.5
Because bovine thrombin is a foreign protein, allergic reac-
tion is possible. Pope and Johnston9 describe an anaphylac-
tic reaction to bovine thrombin injection on the basis of
previous exposure, and Sheldon, Oglevie, and Kaplan8
present a case of prolonged generalized urticaria after fem-
oral artery pseudoaneurysm treatment. Complications of
embolization, arterial thrombosis, groin abscess, and vaso-
spasm have all been described. However, other than the
possibility of allergic reaction, these reports of complica-
tions do not describe contraindications of thrombin injec-
tion therapy of pseudoaneurysms.
We believe that on the basis of our case reports, a
pseudoaneurysm located in the femoral region that is large
enough, or in the right conıguration, to cause an external
compression effect significant enough to lead to DVT of
the femoral vein system should be a contraindication to this
technique. Even though injection may lead to successful
thrombosis of the pseudoaneurysm, the vein is still com-
pressed by the remaining sac or hematoma. The proinflam-
matory activity of thrombin is thought to be the result of
mast cell activation.17 A reactive inflammatory process is
also likely to result in further scarring of this area, com-
pounding this stenosis and venous outflow obstruction. We
believe that if this is the clinical situation with the aneurysm,
surgical exploration should be the treatment of choice to
repair the defect and release the obstruction.
Pseudoaneurysm injection therapy also raises other
clinical concerns. For instance, is there an upper size limit
for thrombin pseudoaneurysm injection just as there is for
ultrasound scan–guided compression? Our experience
would support injection of only those aneurysms that do
not impinge on nearby structures. In addition, the inflam-
matory response caused by thrombin injection makes sub-
sequent surgical exploration difficult. This inflammation
may have contributed to calcification of the sac observed in
our case. The technique also carries the risk of direct venous
injection and subsequent thrombosis.
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Ultrasound scan–guided thrombin injection of pseudo-
aneurysms is an effective therapy for many patients. Com-
plex pseudoaneurysms that involve nearby structures, as
these cases demonstrate, may have a better outcome with
initial direct surgical intervention.
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